MENU
+Compare
LLY
Stock ticker: NYSE
AS OF
Oct 15, 11:16 AM (EDT)
Price
$818.74
Change
+$6.38 (+0.79%)
Capitalization
728.24B

LLY Eli Lilly & Co Forecast, Technical & Fundamental Analysis

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology... Show more

LLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for LLY with price predictions
Oct 14, 2025

LLY's RSI Indicator recovers from overbought zone

The 10-day RSI Indicator for LLY moved out of overbought territory on October 10, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 instances where the indicator moved out of the overbought zone. In of the 42 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 62 cases where LLY's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LLY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

LLY broke above its upper Bollinger Band on October 01, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 01, 2025. You may want to consider a long position or call options on LLY as a result. In of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for LLY just turned positive on October 01, 2025. Looking at past instances where LLY's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

LLY moved above its 50-day moving average on September 30, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for LLY crossed bullishly above the 50-day moving average on September 12, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LLY advanced for three days, in of 375 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 332 cases where LLY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. LLY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (39.841) is normal, around the industry mean (9.641). LLY has a moderately high P/E Ratio (53.095) as compared to the industry average of (24.390). Projected Growth (PEG Ratio) (0.889) is also within normal values, averaging (2.034). LLY has a moderately low Dividend Yield (0.007) as compared to the industry average of (0.028). LLY's P/S Ratio (13.755) is very high in comparison to the industry average of (3.560).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
LLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

LLY is expected to report earnings to $6.33 per share on October 30

Eli Lilly & Co LLY Stock Earnings Reports
Q3'25
Est.
$6.33
Q2'25
Beat
by $0.72
Q1'25
Missed
by $0.12
Q4'24
Beat
by $0.02
Q3'24
Missed
by $0.27
The last earnings report on August 07 showed earnings per share of $6.31, beating the estimate of $5.59. With 363.85K shares outstanding, the current market capitalization sits at 728.24B.
A.I.Advisor
published Dividends

LLY paid dividends on September 10, 2025

Eli Lilly & Co LLY Stock Dividends
А dividend of $1.50 per share was paid with a record date of September 10, 2025, and an ex-dividend date of August 15, 2025. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
Lilly Corporate Center
Phone
+1 317 276-2000
Employees
43000
Web
https://www.lilly.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PRLD1.300.05
+4.00%
Prelude Therapeutics
PLUS72.702.34
+3.33%
ePlus
RRBI66.161.78
+2.76%
Red River Bancshares
CHSCN25.03-0.11
-0.46%
CHS
AR31.61-0.81
-2.50%
ANTERO RESOURCES Corp

LLY and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, LLY has been loosely correlated with AZN. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if LLY jumps, then AZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LLY
1D Price
Change %
LLY100%
-0.86%
AZN - LLY
46%
Loosely correlated
+0.72%
MRK - LLY
40%
Loosely correlated
-1.17%
PFE - LLY
36%
Loosely correlated
-0.85%
OGN - LLY
36%
Loosely correlated
-0.42%
NVS - LLY
32%
Poorly correlated
+0.88%
More